Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.
Saved in:
| Title: | Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor. |
|---|---|
| Authors: | Helman E; Guardant Health Inc, Redwood City, CA. Electronic address: ehelman@guardanthealth.com., Nguyen M; Clovis Oncology Inc, Boulder, CO., Karlovich CA; Frederick National Laboratory for Cancer Research, Frederick, MD., Despain D; Clovis Oncology Inc, Boulder, CO., Choquette AK; Virginia Cancer Specialists Research Institute, Fairfax, VA., Spira AI; Virginia Cancer Specialists Research Institute, Fairfax, VA., Yu HA; Memorial Sloan Kettering Cancer Center, New York, NY., Camidge DR; University of Colorado, Aurora, CO., Harding TC; Clovis Oncology Inc, Boulder, CO., Lanman RB; Guardant Health Inc, Redwood City, CA., Simmons AD; Clovis Oncology Inc, Boulder, CO. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2018 Nov; Vol. 19 (6), pp. 518-530.e7. Date of Electronic Publication: 2018 Aug 07. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0690 |
|---|---|
| DOI: | 10.1016/j.cllc.2018.07.008 |
